User login
SAN FRANCISCO – Forty-seven children referred to Children’s Hospital of Georgia’s rheumatology clinic in Augusta for work-up of autoimmune vasculopathy had vasculopathy symptoms triggered by their ADHD stimulants.
They had been referred by primary care providers who told families that their children probably had an autoimmune disease; the families were relieved to find out that they did not, according to Dr. Rita Jerath, a pediatric rheumatologist in the department of rheumatology, Medical College of Georgia, Augusta.
The findings show that psychostimulant-induced peripheral vasculopathy, a known side effect included in the labeling of drugs such as methylphenidate (Ritalin or Concerta), dexmethylphenidate (Focalin), and amphetamine/dextroamphetamine (Adderall), is underrecognized in the medical community, leading to needless anxiety and unnecessary medical expenses, she noted.
Although uncommon, “there is a strong association between the use of psychostimulants and peripheral vasculopathy symptoms. Our study demonstrates the need of making prescribing physicians aware of this significant side effect so they may educate the families and also elucidate occurrence of new vascular symptoms [in] this patient population,” noted Dr. Jerath.
“A lot of rheumatologists will recognize this, but we want to get this message across to primary care physicians and families,” she added.
She had several tips for recognizing the problem. Otherwise well children seem to have Raynaud’s disease, “but their signs and symptoms are different,” she said. The color change is more extensive, on the tops of hands and feet, and more dusky and cyanotic. Hands and feet can be cold, numb, and painful, but the condition doesn’t change with cold or stress, as in Raynaud’s. Children can be positive for antinuclear antibodies, as several were in the study, Dr. Jerath said.
Children are usually on their psychostimulants from a few months or few years before an attack, and attacks seem to be triggered by a change in dose or drug.
The symptoms often improve with a drug holiday, for instance during vacation.
Although families are glad to learn their children don’t have an autoimmune disease, they are often reluctant to discontinue the stimulants. “A lot of times, the question is, ‘What else is available?’ There are a few medications that are not psychostimulants – Straterra [atomoxetine] is one – but usually physicians find they are not as helpful,” Dr. Jerath said.
The investigators had no disclosures.
SAN FRANCISCO – Forty-seven children referred to Children’s Hospital of Georgia’s rheumatology clinic in Augusta for work-up of autoimmune vasculopathy had vasculopathy symptoms triggered by their ADHD stimulants.
They had been referred by primary care providers who told families that their children probably had an autoimmune disease; the families were relieved to find out that they did not, according to Dr. Rita Jerath, a pediatric rheumatologist in the department of rheumatology, Medical College of Georgia, Augusta.
The findings show that psychostimulant-induced peripheral vasculopathy, a known side effect included in the labeling of drugs such as methylphenidate (Ritalin or Concerta), dexmethylphenidate (Focalin), and amphetamine/dextroamphetamine (Adderall), is underrecognized in the medical community, leading to needless anxiety and unnecessary medical expenses, she noted.
Although uncommon, “there is a strong association between the use of psychostimulants and peripheral vasculopathy symptoms. Our study demonstrates the need of making prescribing physicians aware of this significant side effect so they may educate the families and also elucidate occurrence of new vascular symptoms [in] this patient population,” noted Dr. Jerath.
“A lot of rheumatologists will recognize this, but we want to get this message across to primary care physicians and families,” she added.
She had several tips for recognizing the problem. Otherwise well children seem to have Raynaud’s disease, “but their signs and symptoms are different,” she said. The color change is more extensive, on the tops of hands and feet, and more dusky and cyanotic. Hands and feet can be cold, numb, and painful, but the condition doesn’t change with cold or stress, as in Raynaud’s. Children can be positive for antinuclear antibodies, as several were in the study, Dr. Jerath said.
Children are usually on their psychostimulants from a few months or few years before an attack, and attacks seem to be triggered by a change in dose or drug.
The symptoms often improve with a drug holiday, for instance during vacation.
Although families are glad to learn their children don’t have an autoimmune disease, they are often reluctant to discontinue the stimulants. “A lot of times, the question is, ‘What else is available?’ There are a few medications that are not psychostimulants – Straterra [atomoxetine] is one – but usually physicians find they are not as helpful,” Dr. Jerath said.
The investigators had no disclosures.
SAN FRANCISCO – Forty-seven children referred to Children’s Hospital of Georgia’s rheumatology clinic in Augusta for work-up of autoimmune vasculopathy had vasculopathy symptoms triggered by their ADHD stimulants.
They had been referred by primary care providers who told families that their children probably had an autoimmune disease; the families were relieved to find out that they did not, according to Dr. Rita Jerath, a pediatric rheumatologist in the department of rheumatology, Medical College of Georgia, Augusta.
The findings show that psychostimulant-induced peripheral vasculopathy, a known side effect included in the labeling of drugs such as methylphenidate (Ritalin or Concerta), dexmethylphenidate (Focalin), and amphetamine/dextroamphetamine (Adderall), is underrecognized in the medical community, leading to needless anxiety and unnecessary medical expenses, she noted.
Although uncommon, “there is a strong association between the use of psychostimulants and peripheral vasculopathy symptoms. Our study demonstrates the need of making prescribing physicians aware of this significant side effect so they may educate the families and also elucidate occurrence of new vascular symptoms [in] this patient population,” noted Dr. Jerath.
“A lot of rheumatologists will recognize this, but we want to get this message across to primary care physicians and families,” she added.
She had several tips for recognizing the problem. Otherwise well children seem to have Raynaud’s disease, “but their signs and symptoms are different,” she said. The color change is more extensive, on the tops of hands and feet, and more dusky and cyanotic. Hands and feet can be cold, numb, and painful, but the condition doesn’t change with cold or stress, as in Raynaud’s. Children can be positive for antinuclear antibodies, as several were in the study, Dr. Jerath said.
Children are usually on their psychostimulants from a few months or few years before an attack, and attacks seem to be triggered by a change in dose or drug.
The symptoms often improve with a drug holiday, for instance during vacation.
Although families are glad to learn their children don’t have an autoimmune disease, they are often reluctant to discontinue the stimulants. “A lot of times, the question is, ‘What else is available?’ There are a few medications that are not psychostimulants – Straterra [atomoxetine] is one – but usually physicians find they are not as helpful,” Dr. Jerath said.
The investigators had no disclosures.
AT THE ACR ANNUAL MEETING
Key clinical point: ADHD stimulants can cause peripheral vasculopathy.
Major finding: Forty-seven children with stimulant-induced peripheral vasoconstriction were misdiagnosed with autoimmune disease.
Data source: A review of 47 pediatric ADHD cases.
Disclosures: The investigators had no disclosures.
